Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101847.pdf 0001209191-16-101847.rtf 0001209191-16-101847.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101855.pdf 0001209191-16-101855.rtf 0001209191-16-101855.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101851.pdf 0001209191-16-101851.rtf 0001209191-16-101851.xls View HTML
February 24, 2016	4	Statement of changes in beneficial ownership of securities	0001209191-16-101849.pdf 0001209191-16-101849.rtf 0001209191-16-101849.xls View HTML
February 12, 2016	SC 13G/A	An amendment to the SC 13G filing	0000897069-16-000698.pdf 0000897069-16-000698.rtf 0000897069-16-000698.xls View HTML
February 12, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000315066-16-004791.pdf 0000315066-16-004791.rtf View HTML
February 12, 2016	SC 13G/A	An amendment to the SC 13G filing	0001193125-16-461770.pdf 0001193125-16-461770.rtf 0001193125-16-461770.xls View HTML
February 10, 2016	S-8	Securities offered to employees pursuant to employee benefit plans	0001193125-16-457756.pdf 0001193125-16-457756.rtf 0001193125-16-457756.xls View HTML
January 28, 2016	SC 13G	A statement of beneficial ownership of common stock by certain persons	0000215457-16-004460.pdf 0000215457-16-004460.rtf View HTML
January 25, 2016	SC 13G/A	An amendment to the SC 13G filing	0000790502-16-000061.pdf 0000790502-16-000061.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax